Yaz (Yasmin and Ocella) Injuries

Injuries from Side Effects of Yaz (Yasmin and Ocella)

In April 2012, the FDA issued a Yaz (Yasmin and Ocella) Drug Safety Labeling Change to warn the public that Yaz (Yasmin and Ocella) users may be three times more likely to develop blood clots than those taking other birth control pills. The risks linked to Yaz (Yasmin and Ocella) have been scientifically established by various studies, including studies funded by the FDA itself.

Injuries associated with Yaz, Yasmin or Ocella are serious and can be fatal. They include:

  • Blood clots
  • Deep vein thrombosis (DVT)
  • Pulmonary embolism (clot in the lungs)
  • Venous thromboembolism (VTE)
  • Other thrombotic events
  • Heart attack (when clots travel to heart)
  • Stroke (clot in the brain)
  • Death

Some patients have incurred large medical bills to treat Yaz (Yasmin and Ocella) related injuries. Others have required hospitalization or surgery and been left with long-term, permanent disability. Recovery – if possible at all – can be a long and costly road.

The Driscoll Firm, LLC, is committed to helping Yaz (Yasmin and Ocella) victims. The firm is currently investigating national Yaz (Yasmin and Ocella) injury claims and accepting new cases for potential Yaz, Yasmin or Ocella lawsuits. If you or a loved one has suffered from blood clots, a pulmonary embolism, deep vein thrombosis (DVT), stroke or heart attack, call The Driscoll Firm, LLC, at 314-932-3232 today to speak to an experienced Yaz (Yasmin and Ocella) injury attorney about your case.

Blood Clot Injuries and Yaz (Yasmin and Ocella)

Since May 2011, the FDA has issued warnings of a possible increased risk of blood clots with birth control pills containing the synthetic hormone drospirenone. These medications include Yaz, Yasmin or Ocella (sold generically as Gianvi and Loryna), as well as Yasmin (generics Ocella, Syeda and Zarah), Beyaz and Safyral.

Bayer HealthCare Pharmaceuticals, which manufactures and sells Yaz, Yasmin or Ocella, says on its Yaz (Yasmin and Ocella) website that Yaz, Yasmin or Ocella increases the risk of blood clots, particularly during the first year of use.

The most dangerous clots are those that travel to or occur in the brain, heart or lungs:

  • Stroke. A stroke happens when the brain receives insufficient blood and oxygen. Strokes can be fatal if not quickly treated. Victims may suffer brain damage resulting in paralysis, loss of speech, loss of bowel control, inability to recall words or combine them into phrases (aphasia), changes in ability to think or reason, changes in behavior, memory problems, poor judgment, and other physical and mental problems.
  • Heart attack. Most heart attacks are caused by a blood clot that blocks one of the coronary arteries that supply blood and oxygen to the heart. If the blood flow is blocked, the heart is starved of oxygen and heart cells die. Some heart attacks are fatal. Patients that recover might have to take medication for the rest of their lives, in addition to requiring physical or occupational therapy. Some experience psychological problems such as depression or anxiety. After a person has had a heart attack, there is a greater risk of having another one.
  • Pulmonary embolism. A pulmonary embolism is a blockage of an artery in the lung, most often from a blood clot that has traveled from elsewhere in the body through the bloodstream. It most commonly results from a Deep Vein Thrombosis or DVT (blood clot in the deep veins of the leg or pelvis) that breaks off and migrates to the lung. This is referred to as Venous Thromboembolism (VTE).

Yaz (Yasmin and Ocella) Linked to DVT and Pulmonary Embolism

Some woman who experience Deep Vein Thrombosis (DVT) will not have symptoms. Others might experience some of the following symptoms:

  • Swelling, tenderness, sudden pain and/or blue discoloration in the legs and/or arms
  • Chest pain, shortness of breath, blood-tinged coughing, fever
  • Diarrhea, vomiting, severe abdominal pain
  • Wheezing, painful breathing, dizziness
  • Fainting, heart arrhythmia, pain in the shoulders, upper abdomen and/or back.

Of the approximately 12,000 Yaz, Yasmin and Ocella lawsuits that have been filed in the U.S., many of them allege DVTs and/or pulmonary embolism.

The long-term health prospects of people who survive a pulmonary embolism, stroke or heart attack can be grim. Treatment might require expensive drugs, therapy and therapeutic devices. Paralysis or other severe disability can necessitate modifications to homes due to limited mobility. Some patients need specialized in-home health care.

The financial consequences can be catastrophic. In addition to hospital bills, doctor bills and other medical expenses, families often suffer lost income because the Yaz (Yasmin and Ocella) victim is unable to work.

Contact a Yaz (Yasmin and Ocella) Litigation Lawyer Today

The Driscoll Firm, LLC, and its lawyers are investigating national injury claims related to the side effects from Yaz, Yasmin or Ocella. The maker of Yaz (Yasmin and Ocella), Bayer HealthCare, has already paid more than $400 million to settle close to 2,000 lawsuits. These lawsuits allege various blood clot-related injuries.

If you or a loved one has taken Yaz, Yasmin or Ocella as prescribed and suffered blood clots, stroke, heart attack, pulmonary embolism, deep vein thrombosis, or another side effect that has adversely affected your life, call today to speak to one of our attorneys at 314-932-3232. The Driscoll Firm has represented clients injured by dangerous pharmaceuticals and medical devices for more than a decade and has recovered nearly $170 million in settlements for our clients in the last three years alone.

For more information:

Information about Drospirenone:

Information on blood clots

Benefactor of Public Justice